Markets & Stocks
MGC Pharma In ‘Critical Financial Juncture’ As It Launches Restructuring Plan, Europes First Cannabis ETF To Be Merged As ‘No Longer Viable’, & More From Akanda
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals, which became the first cannabis company to list on the London Stock Exchange (LSE) in 2021, informed investors this week that due to adverse market conditions it ‘finds itself at a critical financial juncture’.
